{"disease":{"id":"oral-squamous-cell-carcinoma-oscc","name":"oral squamous cell carcinoma oscc"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04270201","title":"Determination of ALDH1b1 and ALDH2 Polymorphisms Frequency in the Brazilian Population","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Instituto do Cancer do Estado de São Paulo","has_results":false},{"nct_id":"NCT06599801","title":"Clinical Outcomes of Thoracodorsal Artery Flap in Oral and Maxillofacial Reconstruction","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":217,"lead_sponsor_name":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","has_results":false},{"nct_id":"NCT07371611","title":"Sintilimab Plus Chemotherapy as Neoadjuvant and Adjuvant Treatment for Locally Advanced Oral Squamous Cell Carcinoma","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":104,"lead_sponsor_name":"Qunxing Li,MD","has_results":false},{"nct_id":"NCT07137858","title":"Adebrelimab Combined With Carboplatin and Albumin-bound Taxanol in the Treatment of Resectable Locally Advanced Oral Squamous Cell Carcinoma Cardiac, Randomized, Phase II Exploratory Study","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":70,"lead_sponsor_name":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","has_results":false},{"nct_id":"NCT06861712","title":"Chemoimmunotherapy With or Without SBRT Before Surgery for Locally Advanced Oral and Oropharyngeal Cancer","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":50,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT07028918","title":"A Prospective Single-Arm Study（NCLDR）","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":35,"lead_sponsor_name":"Qilu Hospital of Shandong University","has_results":false},{"nct_id":"NCT07133958","title":"A Bidirectional Observational Clinical Study of NAIC in the Treatment of Tumor Regression Patterns in LA-OSCC and LA-OPSCC","phase":"","overall_status":"RECRUITING","enrollment_count":35,"lead_sponsor_name":"Zhujiang Hospital","has_results":false},{"nct_id":"NCT07015333","title":"Case Review of Patients With Betel Nut-induced Oral Cancer Treated With Pembrolizumab and Cetuximab","phase":"","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"Commonwealth Healthcare Corporation","has_results":false}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}